Eaton Vance Management’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-100
Closed 2819
2021
Q3
$0 Buy
+100
New ﹤0.01% 2122